Form D · Biotechnology
O2 MEDTECH INC
Los Altos, CA · CIK 0001423937
Offering snapshot reported Oct 13, 2011 · SEC filing
- Reported sold
- $3.61M Offering amount: $5.11M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2011 | Initial | $3,609,014 | No comparison | 6 | SEC filing |
| Mar 4, 2011 | Initial | $1,535,307 | No comparison | 6 | SEC filing |
| May 18, 2010 | Initial | $2,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-167163
Source: Form D, filed Oct 13, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Chan | Executive |
| Gordon Hull | Director |
| John Pavlidis | Director |
| Kevin Rooney | Executive |
| Shih Ping (Bob) Wang | Director, Executive |
| Wayne Wu | Director |
| Zengpin Yu | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4984 El Camino Real Suite 115
Los Altos, CA, 94022
Los Altos, CA, 94022